Blood cancers, including leukemia, lymphoma, and myeloma, affect the body's blood-forming tissues and immune system. Recent advancements in treatment, such as targeted therapies and immunotherapies, are significantly improving outcomes for patients. This session will explore the latest breakthroughs in blood cancer research, highlighting the progress made in diagnosis, treatment options, and the development of personalized medicine for these complex cancers.
Tracks:
Track 9-1: Types of Blood Cancer
Track 9-2: Stem Cell Transplants
Track 9-3: Targeted Therapies
Track 9-4: Immunotherapy for Blood Cancer
Track 9-5: Long-Term Management
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
